ARTICLE | Company News
Bioclassifier LLC, NanoString deal
December 13, 2010 8:00 AM UTC
NanoString received exclusive, worldwide rights to use Bioclassifier's PAM50 gene signature to develop in vitro diagnostic and research products for breast cancer intrinsic subtyping. PAM50 is a panel...